Japan, Oct. 9 -- TAKEDA PHARMACEUTICAL CO LTD has got intellectual property rights for 'NON-ADULT HUMAN DOSING OF ANTI-CD30 ANTIBODY-DRUG CONJUGATES.' Other related details are as follows:

Application Number: JP,2025-000019

Category (FI): A61P35/00,A61K47/68,A61P35/02

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Jan. 5, 2025

Publication Date: March 7, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....